PT78699A - Processo para a preparacao de uma formulacao de cefaclor(mono-hidrato do acido 3-cloro-7-d-(2-fenilglicinamido)-3-cefem-4-carboxilico)de accao prolongada - Google Patents

Processo para a preparacao de uma formulacao de cefaclor(mono-hidrato do acido 3-cloro-7-d-(2-fenilglicinamido)-3-cefem-4-carboxilico)de accao prolongada

Info

Publication number
PT78699A
PT78699A PT78699A PT7869984A PT78699A PT 78699 A PT78699 A PT 78699A PT 78699 A PT78699 A PT 78699A PT 7869984 A PT7869984 A PT 7869984A PT 78699 A PT78699 A PT 78699A
Authority
PT
Portugal
Prior art keywords
cefaclor
phenylglycylamid
cefem
chloro
formulation
Prior art date
Application number
PT78699A
Other languages
English (en)
Other versions
PT78699B (en
Inventor
Teruo Sakamoto
Sadao Kawai
Kinzaburo Noda
Toyohiko Takeda
Hiroshi Kato
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of PT78699A publication Critical patent/PT78699A/pt
Publication of PT78699B publication Critical patent/PT78699B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT78699A 1983-06-15 1984-06-06 Process for preparing a long-acting formulation of cefaclor<3- chloro-7-d-(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate PT78699B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58108289A JPS601128A (ja) 1983-06-15 1983-06-15 作用持続型セフアクロル製剤

Publications (2)

Publication Number Publication Date
PT78699A true PT78699A (pt) 1985-01-01
PT78699B PT78699B (en) 1986-07-15

Family

ID=14480890

Family Applications (1)

Application Number Title Priority Date Filing Date
PT78699A PT78699B (en) 1983-06-15 1984-06-06 Process for preparing a long-acting formulation of cefaclor<3- chloro-7-d-(2-phenylglycinamido)-3-cephem-4-carboxylic acid monohydrate

Country Status (23)

Country Link
US (1) US4713247A (pt)
EP (1) EP0129382B1 (pt)
JP (1) JPS601128A (pt)
KR (1) KR910004573B1 (pt)
AT (1) ATE56869T1 (pt)
AU (1) AU568654B2 (pt)
BG (1) BG60261B2 (pt)
CA (1) CA1213218A (pt)
DD (1) DD216163A5 (pt)
DE (1) DE3483282D1 (pt)
DK (2) DK291884A (pt)
ES (1) ES8602407A1 (pt)
FI (1) FI84556C (pt)
GB (1) GB2141342B (pt)
GR (1) GR81598B (pt)
HU (1) HU193434B (pt)
IE (1) IE58278B1 (pt)
IL (1) IL72083A (pt)
NZ (1) NZ208345A (pt)
PH (1) PH19902A (pt)
PT (1) PT78699B (pt)
RO (1) RO88924A (pt)
ZA (1) ZA844357B (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229132A (en) * 1985-02-22 1993-07-20 Grimberg Georges Serge Non-absorbable gastrointestinal medicament provided for treating the two levels of the digestive tract at the same time
JPS61210025A (ja) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk 安定化された抗生物質複合顆粒製剤
AU591248B2 (en) * 1986-03-27 1989-11-30 Kinaform Technology, Inc. Sustained-release pharaceutical preparation
JPS62226926A (ja) * 1986-03-27 1987-10-05 Teisan Seiyaku Kk 持続性複合顆粒剤
JPH0714863B2 (ja) * 1986-06-02 1995-02-22 忠生 白石 時差溶解性の入浴剤
NZ223619A (en) * 1987-02-27 1990-10-26 Lilly Co Eli Sustained release tablet containing cefaclor, a hydrophilic polymer and an acrylic polymer
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
BE1002079A4 (fr) * 1988-07-01 1990-06-19 S M B Lab Composition pharmaceutique d'erythromycine a liberation prolongee, sa preparation et son utilisation.
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
CA2085342A1 (en) * 1990-06-14 1991-12-15 Milton R. Kaplan Stable aqueous drug suspensions
GB9318641D0 (en) * 1993-09-08 1993-10-27 Edko Trading Representation Compositions
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
AU5107496A (en) * 1996-03-13 1997-10-01 Labtec Gesellschaft Fur Technologische Forschung Und Entwicklung Mbh Medicament preparation for angiotensin converting enzyme (ace)-inhibitors
US5948440A (en) * 1997-12-17 1999-09-07 Ranbaxy Laboratories Limited Modified release matrix formulation of cefaclor and cephalexin
ZA98728B (en) * 1998-01-29 1998-10-28 Ranbaxy Lab Ltd Modified release matrix formulations of cefactor and cephalexin
KR100296413B1 (ko) * 1998-04-01 2001-11-14 김선진 세파클러함유서방성정제
EP1191924A4 (en) * 1999-04-06 2005-02-09 Pharmaquest Ltd PHARMACEUTICAL PHARMACEUTICAL FORM FOR PULSED ADMINISTRATION OF (D-THREO) METHYLPHENIDATE AND ANOTHER CNS STIMULATING SUBSTANCE
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
EP1180022A4 (en) * 1999-05-14 2004-01-07 Lilly Co Eli PROCESS FOR THE MASS PRODUCTION OF PHARMACEUTICAL MATERIAL WITH UNIFORM SOLUBILITY
US6596307B1 (en) 1999-06-15 2003-07-22 Eli Lilly And Company Process for preparing pharmaceutical bulk material having uniform dissolution
US7025989B2 (en) * 2000-02-24 2006-04-11 Advancis Pharmaceutical Corp. Multiple-delayed released antibiotic product, use and formulation thereof
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
CA2400818C (en) * 2000-02-24 2009-01-06 Advancis Pharmaceutical Corporation Antibiotic and antifungal compositions
WO2001062229A1 (en) * 2000-02-24 2001-08-30 Advanced Pharma, Inc. Therapeutic product, use and formulation thereof
CA2399856C (en) * 2000-02-24 2009-01-27 Edward M. Rudnic Antibiotic composition with inhibitor
WO2002056867A2 (en) * 2001-01-18 2002-07-25 Natco Pharma Limited Extended release pharmaceutical compositions containing beta-lactam antibiotics
CA2478121A1 (en) * 2002-03-07 2003-09-18 Advancis Pharmaceutical Corporation Antibiotic composition
WO2003094899A1 (es) * 2002-05-09 2003-11-20 Diffucap-Chemobras Química E Farmacéutica, Ltda. Nuevo procedimiento para la preparacion de composiciones de liberacion programada conteniendo (s) -1- [n-[1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl]-l-proline, y al producto obtenido por dicho procedimiento
JP2006528185A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2006528190A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2006528189A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質産物、その使用法および製剤
CA2535398C (en) * 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
JP2007513869A (ja) * 2003-09-15 2007-05-31 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
US20060233878A1 (en) * 2003-09-30 2006-10-19 Lupin Limited Extended release formulation of beta-lactam antibiotics
AU2006235483B2 (en) * 2005-04-12 2010-11-25 Elan Pharma International Limited Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
US20060287212A1 (en) * 2005-06-02 2006-12-21 Novozymes A/S Blends of inactive particles and active particles
CN101188997A (zh) 2005-06-02 2008-05-28 诺维信公司 非活性粒子和活性粒子的混合物
PT2391355T (pt) 2009-05-19 2017-02-21 Celgene Corp Formulações de 4-amino-2-(2,6-dioxopiperidin-3-il)isoindolino-1,3-diona
BR112014014805A2 (pt) * 2011-12-19 2017-06-13 Salix Pharmaceuticals Ltd processos para tratamento e prevenção de constipação induzida por opióide que utilizam composições orais de metilnaltrexona
CA2902911C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
CN104688701A (zh) * 2015-03-20 2015-06-10 江苏亚邦强生药业有限公司 一种头孢克洛片剂及其制备方法
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
CN110408670A (zh) * 2019-08-19 2019-11-05 苏州盛达药业有限公司 一种酶催化合成头孢克洛的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738303A (en) * 1952-07-18 1956-03-13 Smith Kline French Lab Sympathomimetic preparation
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
JPS52139713A (en) * 1976-05-13 1977-11-21 Shionogi & Co Ltd Sustained release cefalexin preparations
US4250166A (en) * 1977-05-27 1981-02-10 Shionogi & Co., Ltd. Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
GR74995B (pt) * 1980-08-27 1984-07-12 Ciba Geigy Ag
JPS5826816A (ja) * 1981-08-11 1983-02-17 Teisan Seiyaku Kk 球形顆粒からなる持続性複合顆粒剤

Also Published As

Publication number Publication date
EP0129382A3 (en) 1986-07-09
EP0129382A2 (en) 1984-12-27
BG60261B1 (bg) 1994-03-31
ZA844357B (en) 1985-06-26
BG60261B2 (en) 1994-03-31
DE3483282D1 (de) 1990-10-31
FI84556B (fi) 1991-09-13
IL72083A0 (en) 1984-10-31
FI842406A0 (fi) 1984-06-13
FI84556C (fi) 1991-12-27
DK291884A (da) 1984-12-16
KR850000242A (ko) 1985-02-26
FI842406A (fi) 1984-12-16
GR81598B (pt) 1984-12-11
PT78699B (en) 1986-07-15
HU193434B (en) 1987-10-28
JPS601128A (ja) 1985-01-07
ES533901A0 (es) 1985-12-01
GB2141342A (en) 1984-12-19
AU568654B2 (en) 1988-01-07
JPS6232166B2 (pt) 1987-07-13
ATE56869T1 (de) 1990-10-15
IE841444L (en) 1984-12-15
KR910004573B1 (ko) 1991-07-06
DK291884D0 (da) 1984-06-14
DK170922B1 (da) 1996-03-18
CA1213218A (en) 1986-10-28
AU2941884A (en) 1984-12-20
IL72083A (en) 1987-10-30
PH19902A (en) 1986-08-13
ES8602407A1 (es) 1985-12-01
US4713247A (en) 1987-12-15
EP0129382B1 (en) 1990-09-26
RO88924A (ro) 1986-04-30
IE58278B1 (en) 1993-08-25
GB8414633D0 (en) 1984-07-11
NZ208345A (en) 1986-12-05
HUT34692A (en) 1985-04-28
GB2141342B (en) 1986-11-12
DD216163A5 (de) 1984-12-05

Similar Documents

Publication Publication Date Title
PT78699A (pt) Processo para a preparacao de uma formulacao de cefaclor(mono-hidrato do acido 3-cloro-7-d-(2-fenilglicinamido)-3-cefem-4-carboxilico)de accao prolongada
HUT46699A (en) Process for producing phosphinic acid derivatives and pharmaceutical compositions containing them as active components
CS195285A3 (en) Pyridazine derivatives substituted by cyclic amines and process forpreparing thereof
HUT47131A (en) Process for producing steroid-5alpha-reductase inhibitors and pharmaceutical compositions comprising them as active ingredient
ATE110745T1 (de) Wachstumshormonkristalle und verfahren zu deren herstellung.
HUT48247A (en) Process for producing aza-bicyclo-octyl-ether derivatives and pharmaceutical compositions containing them as active components
HUT52500A (en) Process for producing antibacterial 1-terc-alkyl-substituted naphtiridine- and quinoline-carboxylic acids and pharmaceutical compositions containing them as active components
PT84088B (pt) Processo de preparacao de novos derivados do acido 4-amino-9h-pirido 2,3-b indol-carboxilico-(3) e de composicoes farmaceuticas contendo-os
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
HUT51284A (en) Process for production of epipodofillotoxin glucozides substituated by fluor and medical compositions containing them as active substance
HUT48232A (en) Process for producing new biphenyl derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT47947A (en) Process for producing unsaturated amino acid compounds and pharmaceuticals comprising same as active ingredient
HUT47077A (en) Process for producing hydrocinnamomic acid derivatives and pharmaceutical compositions containing them as active components
HUT48885A (en) Process for producing nukleotid-analogues and pharmaceutical compositions containing them as active components
HUT49590A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same as active ingredient
HUT53121A (en) Process for producing amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
IT8620703A1 (it) Derivati dell&#39;acido 4-fenil 4-osso 2-butenoico, loro procedimento di preparazione e loro impiego come prodotti medicinali
HUT47579A (en) Process for production of new imidazo /1,2-a/-pirimidins and their salts and medical compositions containing them as active substance
HUT47899A (en) Process for producing amides of butenic acid and pharmaceutical compositions containing them as active components
MX160768A (es) Proceso para la preparacion del monohidrato del acido 3-amino-2-(5-metoxi-1h-indol-3-il)propionico
HUT48638A (en) Process for producing antracyclin derivatives and pharmaceutical compositions containing them as active components
HUT40428A (en) Process for producing sulfamoyl-benzoic acid derivatives and pharmaceutical compositions containing them as active agents
ATE28189T1 (de) 2-alkylthio-1-aminoalkyl-2-pyrrolin-3carbonitrile, verfahren zu deren herstellung sowie diese enthaltende arzneimittel fuer die prophylaxe und therapie thrombotischer zustaende.
IT1263913B (it) Composti terapeuticamente attivi, utili per il trattamento di malattieconnesse con alterata funzionalita&#39; del sistema immunitario, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT8821189A0 (it) Di estere fosforico dell&#39;acido ursodeossicolico e suoi derivati, processo per la loro preparazione e composizioni terapeutiche che li contengono come principi attivi.